AGRX - Agile Therapeut Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TVIX (0%) DGAZ (0%) IWM (0%) VXX (0%) NBY (0%) MSFT (0%) LVGO (0%) LMRK (0%) KSS (0%) KR (0%) KO (0%) IQ (0%) IMGN (0%) GSK (0%) FEYE (0%) FDX (0%) F (0%) EPZM (0%) ECA (0%) DISH (0%) COST (0%) CHWY (0%) CC (0%) APLE (0%) AMD (0%)

Volume 20% above average | 5% or more down

AGRX - Agile Therapeutics

$1.18 0[0%]

15 mins delayed data

People also watch : TXMD | JNJ | PFE | ATRS | MYL | MRK

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$1.18	Open
Volume		Market Cap	55.12M
Yield		Last Dividend

Day

52 Week

Zynerba Releases Data on Epilepsy Candid...	09/19/19
Zynerba (ZYNE) announces positive top-line results from the BELIEVE 1 study evaluating the efficacy and safety of Zygel in a heterogeneous group of ra...

Agile Therapeutics (AGRX) Upgraded to St...	09/10/19
Agile Therapeutics (AGRX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Th...

Agile Therapeutics to Present at Upcomin...	09/06/19
PRINCETON, N.J., Sept. 06, 2019 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief ...

3 “Strong Buy” Biotech Stocks Ahead of F...	09/05/19
Most biotech stocks have been under pressure recently, but as we approach the end of the year, many analysts are quite bullish as to what is next for ...

ANALYST RATINGS

1 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	06/07/19
Oppenheimer initiates coverage with Outperform rating and announces Price Target of $5.00

EARNINGS

Date	2019-08-01 (AMC)	Est. (EPS/Rev.)	($0.11)/ 0
Actual (EPS/Rev.)	$-0.08/	EPS (TTM)	0

TRADERS TRACKING $AGRX

Service Name	Trader	% Success
Swing Trading Cheap Stocks <~ $10	Michael S. DeVries	75.00 %	Follow
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
R R Investments	Roland Van Rij	17.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%